Gentherm Inc.

07/31/2024 | Press release | Distributed by Public on 07/31/2024 04:11

Gentherm Reports 2024 Second Quarter Results Form 8 K

Gentherm Reports 2024 Second Quarter Results

Record Quarterly Revenue of $376 Million

Highest Quarterly Operating Income in Three Years

Secured $660 Million in Automotive New Business Awards

NORTHVILLE, Michigan, July 31, 2024 /Global Newswire/ -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the second quarter ending June 30, 2024.

Second Quarter Highlights

Product revenues of $375.7 million increased 0.9% from $372.3 million in the second quarter of 2023. Excluding the impact of foreign currency translation, product revenues increased 2.0% year over year
Automotive revenues increased 0.7% year over year; excluding the impact of foreign currency translation, automotive revenues increased 1.8% year over year
GAAP diluted earnings per share was $0.60 as compared with a loss of $0.05 for the prior-year period
Adjusted diluted earnings per share (see table herein) was $0.66. Adjusted diluted earnings per share in the prior-year period was $0.58
Secured automotive new business awards totaling $660 million in the quarter

Phil Eyler, the Company's President and CEO, said, "The financial and operating results of the second quarter demonstrate the continued strong execution of our growth strategy. With record quarterly revenue, the highest quarterly operating income in three years, a 190 basis point year-over-year expansion in Adjusted EBITDA margin rate, and $660 million in automotive new business awards - including our first proprietary Puls.A™ massage solution award, the Gentherm team continues to deliver solid results in this challenging environment.

He continued, "Our Automotive Climate and Comfort Solutions revenue outperformed actual light vehicle production in our key markets by 500 basis points, fueled by double-digit growth in our Lumbar and Massage Comfort Solutions, validating our investment thesis for the strategic acquisition of Alfmeier."

He concluded, "We continue to make significant strides in the development of our next generation technologies, including ClimateSense®, WellSense™, and ComfortScale™. Our second quarter automotive new business awards brought our year-to-date total to $1.2 billion. This momentum, and our continued progress on Fit-For-Growth 2.0, make us confident in our ability to reach high-teens Adjusted EBITDA margin rate over time."

2024 Second Quarter Financial Review

Product revenues for the second quarter of 2024 increased by $3.4 million, or 0.9%, as compared with the prior-year period. Excluding the impact of foreign currency translation, product revenues increased 2.0% year over year.

Automotive revenues increased 0.7% year over year. Adjusting for foreign currency translation, phasing out the non-automotive electronics business as well as one-time benefits from recoveries in both periods, Automotive revenues increased 2.8% year over year. Revenues from Automotive Climate and Comfort Solutions increased 4.8% in the second quarter compared to the prior year period.

According to S&P Global's mid-July report, actual light vehicle production decreased by 0.2% in the second quarter when compared with the same quarter of 2023 in the Company's key markets of North America, Europe, China, Japan, and Korea.

Gentherm Medical revenue increased 8.3% year over year, primarily as a result of higher Blanketrol® sales. Adjusting for the impact of foreign currency translation, Medical revenues increased 8.7%.

See the "Revenues by Product Category and Reconciliation of Foreign Currency Translation Impact" table included below for additional detail.

Gross margin rate increased to 25.7% in the current-year period, as compared with 23.6% in the prior-year period. The increase from the prior-year period was driven by Fit-for-Growth 2.0 initiatives including supplier cost reductions, value engineering activities, and net productivity at the factories as well the impact of our previously announced exit of the non-automotive electronics business. These were partially offset by annual price reductions and start-up costs from our new plants opening in Tangier, Morrocco and Monterrey, Mexico.

Net research and development expenses of $21.9 million in the quarter decreased $2.8 million, or 11.5% over the prior-year period, primarily related to the reduction in resources allocated to certain battery performance solutions products and higher R&D reimbursements.

Selling, general and administrative expenses of $39.4 million in the quarter increased $1.0 million, or 2.6%, versus the prior-year period. The year-over-year increase was primarily driven by higher compensation expenses.

Restructuring expenses of $2.4 million in the current-year period increased $1.4 million, versus the prior-year period primarily as a result of discrete restructuring activities associated with the Company's Fit-for-Growth 2.0 initiatives and previously announced footprint optimization.

As described more fully in the "Reconciliation of Net Income (Loss) to Adjusted EBITDA and Adjusted EBITDA Margin" table included below, the Company recorded Adjusted EBITDA of $49.9 million in the quarter compared with $42.4 million in the prior-year period, an increase of $7.5 million or 17.7%.

Income tax expense in the quarter was $9.5 million, as compared with $4.8 million in the prior-year period. The effective tax rate was approximately 34% in the quarter.

GAAP diluted earnings per share for the quarter was $0.60 compared with a loss of $0.05 for the prior-year period. Adjusted diluted earnings per share, excluding restructuring expenses, non-cash purchase accounting impact, non-automotive electronics inventory benefit, unrealized currency gain, and other items specified on the table below, was $0.66. Adjusted diluted earnings per share in the prior-year period was $0.58.

The Company provides various non-GAAP financial measures in this release. See "Use of Non-GAAP Measures" below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures.

Guidance

The Company's full-year 2024 guidance as of July 31, 2024 is shown below:

Initial 2024 Guidance

Latest Estimate(1)

Product Revenues

$1.5B - $1.6B

Low end of range

Adjusted EBITDA Margin Rate

12.5% - 13.5%

Above mid-point of range

Full-year Adjusted Effective Tax Rate

26% - 29%

No change

Capital Expenditures

$65M - $75M

No change

(1)
Based on the current forecast of customer orders, and light vehicle production in the Company's key markets declining at a low single digit rate in 2024 versus 2023, and a EUR to USD exchange rate of $1.08/Euro for the remainder of the year.

Conference Call

As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13747799.

A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

A telephonic replay will be available at approximately two hours after the call until 11:59 pm Eastern Time on August 14, 2024. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13747799.

Investor Contact
Gregory Blanchette
[email protected]
248.308.1702

Media Contact
Melissa Fischer
[email protected]
248.289.9702

About Gentherm

Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, Morocco, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.

Forward-Looking Statements

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
increasing U.S. and global competition, including with non-traditional entrants;
our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
the evolution and recent challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
our ability to convert automotive new business awards into product revenues;
the recent supply-constrained environment, and inflationary and other cost pressures;
the production levels of our major customers and OEMs in our key markets and sudden fluctuations in such production levels;
our business in China, which is subject to unique operational, competitive, regulatory and economic risks;
our ability to attract and retain highly skilled employees and wage inflation;
a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;
our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
our product quality and safety and impact of product safety recalls and alleged defects in products;
our ability to integrate our recent acquisitions and realize synergies, as well as to consummate additional strategic acquisitions, investments and exits, and achieve planned benefits;
any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks;
the impact of our global operations, including our global supply chain, operations within Ukraine, economic and trade policies, and foreign currency and exchange risk;
any loss or insolvency of our key customers and OEMs, or key suppliers;
our efforts to optimize our global supply chain and manufacturing footprint;
our ability to project future sales volume based on third-party information, based on which we manage our business;
the protection of our intellectual property in certain jurisdictions;
our compliance with anti-corruption laws and regulations;
legal and regulatory proceedings and claims involving us or one of our major customers;
the extensive regulation of our patient temperature management business;
risks associated with our manufacturing processes;
the effects of climate change and catastrophic events, as well as regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
our product quality and safety;
our borrowing availability under our revolving credit facility, as well ability to access the capital markets, to support our planned growth; and
our indebtedness and compliance with our debt covenants.

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the "SEC"), including "Risk Factors," in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company's future business and financial results.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Use of Non-GAAP Financial Measures

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"); Adjusted EBITDA margin; adjusted earnings per share ("Adjusted earnings per share" or "Adjusted EPS"); free cash flow; Net Debt, revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Automotive Climate and Comfort Solutions revenues; and adjusted operating expenses, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock-based compensation expenses, and other gains and losses not reflective of the Company's ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company's ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified in the reconciliation tables herein. The Company defines Automotive Climate and Comfort Solutions revenues as Automotive revenue excluding specified product revenues and the impact of non-automotive electronics and contract manufacturing electronics revenues. The Company defines adjusted operating expenses as operating expenses excluding impairment of intangible assets and property and equipment, restructuring, related non-cash stock-based compensation, acquisition, integration and divestiture expenses.

The Company's reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company's Form 8-K dated July 31, 2024.

In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly

assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company's ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income (loss), revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME (LOSS)

(Dollars in thousands, except per share data)

(Unaudited)

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Product revenues

$

375,683

$

372,323

$

731,698

$

735,948

Cost of sales

278,982

284,335

546,244

566,830

Gross margin

96,701

87,988

185,454

169,118

Operating expenses:

Net research and development expenses

21,861

24,696

44,606

49,841

Selling, general and administrative expenses

39,410

38,418

80,131

75,460

Restructuring expenses

2,442

1,044

9,680

2,313

Impairment of goodwill

-

19,509

-

19,509

Total operating expenses

63,713

83,667

134,417

147,123

Operating income

32,988

4,321

51,037

21,995

Interest expense, net

(4,002

)

(1,932

)

(7,246

)

(6,076

)

Foreign currency (loss) gain

(282

)

346

2,267

(1,723

)

Other (loss) income

(284

)

556

689

786

Earnings before income tax

28,420

3,291

46,747

14,982

Income tax expense

9,544

4,842

13,086

8,570

Net income (loss)

$

18,876

$

(1,551

)

$

33,661

$

6,412

Basic earnings (loss) per share

$

0.60

$

(0.05

)

$

1.07

$

0.19

Diluted earnings (loss) per share

$

0.60

$

(0.05

)

$

1.06

$

0.19

Weighted average number of shares - basic

31,534

33,019

31,539

33,100

Weighted average number of shares - diluted

31,710

33,019

31,714

33,328

GENTHERM INCORPORATED

REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT

(Dollars in thousands)

(Unaudited)

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

% Change

2024

2023

% Change

Climate Control Seat

$

121,701

$

121,210

0.4

%

$

237,291

$

235,963

0.6

%

Seat Heaters

77,056

78,258

(1.5

)%

154,132

153,894

0.2

%

Lumbar and Massage Comfort Solutions

45,869

37,604

22.0

%

84,120

76,342

10.2

%

Steering Wheel Heaters

42,414

38,958

8.9

%

82,228

75,305

9.2

%

Valve Systems

29,267

27,692

5.7

%

55,892

54,686

2.2

%

Automotive Cables

18,832

20,243

(7.0

)%

40,351

40,463

(0.3

)%

Battery Performance Solutions

16,063

19,587

(18.0

)%

29,671

39,896

(25.6

)%

Electronics

7,171

9,323

(23.1

)%

15,356

20,293

(24.3

)%

Other Automotive

5,629

8,658

(35.0

)%

9,599

17,383

(44.8

)%

Subtotal Automotive segment

364,002

361,533

0.7

%

708,640

714,225

(0.8

)%

Medical segment

11,681

10,790

8.3

%

23,058

21,723

6.1

%

Total Company

$

375,683

$

372,323

0.9

%

$

731,698

$

735,948

(0.6

)%

Foreign currency translation impact (a)

(3,936

)

-

(6,733

)

-

Total Company, excluding foreign
currency translation impact

$

379,619

$

372,323

2.0

%

$

738,431

$

735,948

0.3

%

(a) Foreign currency translation impacts for the Automotive segment and Medical segment were $(3,891) and $(45) respectively, for the three months ended June 30, 2024. Foreign currency translation impacts for the Automotive segment and Medical segment were $(6,617) and $(116) respectively, for the six months ended June 30, 2024.

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA

AND ADJUSTED EBITDA MARGIN

(Dollars in thousands)

(Unaudited)

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Net income (loss)

$

18,876

$

(1,551

)

$

33,661

$

6,412

Add back:

Depreciation and amortization

12,811

12,393

26,391

25,838

Income tax expense (a)

9,544

4,842

13,086

8,570

Interest expense, net (b)

4,002

1,932

7,246

6,076

Adjustments:

Non-cash stock-based compensation (c)

3,610

3,076

7,407

5,171

Acquisition and integration expenses

-

1,480

-

3,112

Restructuring expense

2,442

1,044

9,680

2,313

Non-automotive electronics inventory (benefit) charge

(712

)

644

(1,772

)

2,063

Unrealized currency (gain) loss

(497

)

(740

)

(2,353

)

5,125

Impairment of goodwill

-

19,509

-

19,509

Other

(203

)

(251

)

69

(301

)

Adjusted EBITDA

$

49,873

$

42,378

$

93,415

$

83,888

Product revenues

$

375,683

$

372,323

$

731,698

$

735,948

Adjusted EBITDA Margin

13.3

%

11.4

%

12.8

%

11.4

%

(a) Includes $2,423 of deferred income tax benefit associated with goodwill impairment of the Medical reporting unit for the three and six months ended June 30, 2023.

(b) Includes $308 and $4 of interest expense for the three and six months ended June 30, 2024, respectively, related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of $100,000.

(c) Includes operating expenses of $3,519 and $3,076 for the three months ended June 30, 2024 and 2023, respectively. Includes operating expenses of $7,009 and $4,834 for the six months ended June 30, 2024 and 2023, respectively.

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED NET INCOME

AND ADJUSTED EARNINGS PER SHARE

(Dollars in thousands, except per share data)

(Unaudited)

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Net income (loss)

$

18,876

$

(1,551

)

$

33,661

$

6,412

Non-cash purchase accounting impact

1,584

2,330

3,189

4,180

Restructuring expenses

2,442

1,044

9,680

2,313

Unrealized currency (gain) loss

(497

)

(740

)

(2,353

)

5,125

Acquisition and integration expenses

-

1,480

-

3,112

Non-automotive electronics inventory (benefit) charge

(712

)

644

(1,772

)

2,063

Impairment of goodwill

-

19,509

-

19,509

Other

(203

)

(251

)

69

(301

)

Tax effect of above

(454

)

(3,425

)

(1,851

)

(6,942

)

Adjusted net income

$

21,036

$

19,040

$

40,623

$

35,471

Weighted average shares outstanding:

Basic

31,534

33,019

31,539

33,100

Diluted

31,710

33,019

31,714

33,328

Earnings (loss) per share, as reported:

Basic

$

0.60

$

(0.05

)

$

1.07

$

0.19

Diluted

$

0.60

$

(0.05

)

$

1.06

$

0.19

Adjusted earnings per share:

Basic

$

0.67

$

0.58

$

1.29

$

1.07

Diluted

$

0.66

$

0.58

$

1.28

$

1.06

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(Dollars in thousands, except share data)

(Unaudited)

June 30, 2024

December 31, 2023

ASSETS

Current Assets:

Cash and cash equivalents

$

123,466

$

149,673

Accounts receivable, net

264,759

253,579

Inventory:

Raw materials

129,752

126,013

Work in process

17,890

15,704

Finished goods

66,728

64,175

Inventory, net

214,370

205,892

Other current assets

87,091

78,420

Total current assets

689,686

687,564

Property and equipment, net

246,304

245,234

Goodwill

101,822

104,073

Other intangible assets, net

62,082

66,482

Operating lease right-of-use assets

30,631

27,358

Deferred income tax assets

80,264

81,930

Other non-current assets

29,764

21,730

Total assets

$

1,240,553

$

1,234,371

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

Accounts payable

$

222,039

$

215,827

Current lease liabilities

7,087

7,700

Current maturities of long-term debt

268

621

Other current liabilities

96,724

100,805

Total current liabilities

326,118

324,953

Long-term debt, less current maturities

222,134

222,217

Non-current lease liabilities

21,920

16,175

Pension benefit obligation

2,758

3,209

Other non-current liabilities

27,319

23,095

Total liabilities

$

600,249

$

589,649

Shareholders' equity:

Common Stock:

No par value; 55,000,000 shares authorized 31,318,444 and 31,542,001 issued and outstanding at June 30, 2024 and December 31, 2023, respectively

26,539

50,503

Paid-in capital

4,949

-

Accumulated other comprehensive loss

(55,699

)

(30,160

)

Accumulated earnings

664,515

624,379

Total shareholders' equity

640,304

644,722

Total liabilities and shareholders' equity

$

1,240,553

$

1,234,371

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

Six Months Ended June 30,

2024

2023

Operating Activities:

Net income

$

33,661

$

6,412

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

26,733

26,077

Deferred income taxes

4,365

(2,812

)

Stock based compensation

7,392

5,053

(Gain) loss on disposition of property and equipment

(42

)

828

Provisions for inventory

793

1,930

Impairment of goodwill

-

19,509

Other

(863

)

(259

)

Changes in assets and liabilities:

Accounts receivable, net

(14,310

)

(11,624

)

Inventory

(12,338

)

9,417

Other assets

(36,874

)

(12,241

)

Accounts payable

8,436

24,518

Other liabilities

9,871

(8,196

)

Net cash provided by operating activities

26,824

58,612

Investing Activities:

Purchases of property and equipment

(30,704

)

(13,667

)

Proceeds from the sale of property and equipment

81

40

Proceeds from deferred purchase price of factored receivables

6,208

7,351

Cost of technology investments

(265

)

(500

)

Net cash used in investing activities

(24,680

)

(6,776

)

Financing Activities:

Borrowings on debt

35,000

-

Repayments of debt

(35,420

)

(16,982

)

Proceeds from the exercise of Common Stock options

2,763

263

Taxes withheld and paid on employees' stock-based compensation

(2,417

)

(2,644

)

Cash paid for the repurchase of Common Stock

(21,703

)

(19,993

)

Net cash used in financing activities

(21,777

)

(39,356

)

Foreign currency effect

(6,574

)

2,300

Net (decrease) increase in cash and cash equivalents

(26,207

)

14,780

Cash and cash equivalents at beginning of period

149,673

153,891

Cash and cash equivalents at end of period

$

123,466

$

168,671

Supplemental disclosure of cash flow information:

Cash paid for taxes

$

12,300

$

11,619

Cash paid for interest

6,723

6,640

GENTHERM INCORPORATED

OTHER NON-GAAP RECONCILIATIONS

(Dollars in thousands)

(Unaudited)

Three Months Ended June 30,

2024

2023

Automotive revenues

$

364,002

$

361,533

Non-automotive electronics revenues

346

3,609

One-time benefits from recoveries and retrofits

-

269

Adjusted Automotive revenues

363,656

357,655

Foreign currency translation impact

(3,870

)

-

Adjusted Automotive revenues, excluding foreign currency translation impact

$

367,526

$

357,655

Year over Year % change

2.8

%

Three Months Ended June 30,

2024

2023

Automotive revenues

$

364,002

$

361,533

Less: Valve Systems

29,267

27,692

Less: Automotive Cables

18,832

20,243

Less: Battery Performance Solutions

16,063

19,587

Less: Non-automotive and contract manufacturing electronics (a)

3,017

7,385

Automotive Climate and Comfort Solutions revenues

296,823

286,626

Less: One-time benefits from recoveries and retrofits

-

269

Adjusted Automotive Climate and Comfort Solutions revenues

296,823

286,357

Foreign currency translation impact

(3,187

)

-

Adjusted Automotive Climate and Comfort Solutions revenues, excluding foreign currency translation impact

$

300,010

$

286,357

Year over Year % change

4.8

%

(a) In Q1 2024 we did not exclude contract manufacturing electronics revenues from Automotive Climate and Comfort Solutions revenues. Contract manufacturing electronics revenues were $2,699 and $3,850 in Q1 2024 and Q1 2023, respectively.